Peregrine Pharmaceuticals traded at $16.36 this Tuesday July 5th, increasing $1.03 or 6.72 percent since the previous trading session. Looking back, over the last four weeks, Peregrine Pharmaceuticals gained 20.38 percent. Over the last 12 months, its price fell by 38.29 percent. Looking ahead, we forecast Peregrine Pharmaceuticals to be priced at 14.91 by the end of this quarter and at 13.73 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agenus 2.41 0.45 22.96% -55.20%
Amgen 247.39 0.66 0.27% 1.54%
AstraZeneca 11,004.00 204.00 1.89% 27.10%
BioCryst Pharmaceuticals 11.14 0.30 2.77% -31.36%
Bristol-Myers Squibb 76.43 0.47 0.62% 14.67%
ChemoCentryx 26.85 0.09 0.34% 91.10%
Celldex Therapeutics 24.75 2.05 9.03% -20.93%
GlaxoSmithKline 1,791.00 4.40 0.25% 24.63%
Immunogen 4.90 0.29 6.29% -21.60%
Karyopharm Therapeutics 5.31 0.58 12.26% -47.48%
Eli Lilly 328.10 0.92 0.28% 39.37%
MacroGenics 3.31 0.26 8.52% -88.38%
MannKind 4.05 0.07 1.76% -22.41%
Merck & Co 93.98 1.34 1.45% 20.32%
Minerva Neurosciences 3.25 -0.34 -9.47% 40.09%
Lumos Pharma Inc. 7.59 -0.10 -1.30% -24.10%
Novartis 81.21 0.30 0.37% -4.43%
Novavax 64.29 7.14 12.49% -70.12%
Peregrine Pharmaceuticals 16.36 1.03 6.72% -38.29%
Repligen 167.68 1.16 0.70% -17.83%
Roche Holding 324.55 5.55 1.74% -8.82%
Xencor 30.45 1.59 5.51% -11.84%
Intrexon 1.62 0.21 14.89% -74.12%

Indexes Price Day Year
USND 11322 194.39 1.75% -22.79%
US2000 1741 13.57 0.79% -23.44%

Peregrine Pharmaceuticals
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.